o-Methylcinnamic acid → (E)-N-[1-(5-Oxo-hexyl)-1H-pyrazol-3-yl]-3-o-tolyl-acrylamide
Reaction equation
[CH3:1][C:2]1([CH2:7][CH2:8][CH2:9][CH2:10][N:11]2[CH:15]=[CH:14][C:13]([NH2:16])=[N:12]2)[O:6]CCO1.[C:17]1([CH3:28])[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=1/[CH:23]=[CH:24]/[C:25](O)=[O:26]>>[O:6]=[C:2]([CH3:1])[CH2:7][CH2:8][CH2:9][CH2:10][N:11]1[CH:15]=[CH:14][C:13]([NH:16][C:25](=[O:26])/[CH:24]=[CH:23]/[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[CH3:28])=[N:12]1Participants
3
Procedure
Following general procedure B followed by either C or D, starting from 1-[4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-1H-pyrazol-3-ylamine and (E)-3-o-tolyl-acrylic acid.
Sources & evidence
- ORD record
- ord-77a26709112348af99d248f2e67c9b7d
- Source dataset
- uspto-grants-2012_10
- Patent number
- US08288419B2
Reaction notes
Loading…